Matches in SemOpenAlex for { <https://semopenalex.org/work/W2095668671> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2095668671 abstract "Rivastigmine is a cholinesterase inhibitor used for the treatment of Alzheimer disease (AD) that provides positive effects on cognition, behaviour, and function. Proton Magnetic Resonance Spectroscopy (1 H MRS) has been previously used to monitor metabolic changes in brain tissue following cholinesterase inhibitor treatment in subjects with AD. The purpose of this study was to compare metabolic changes in the posterior cingulate to changes in cognition in subjects with AD following rivastigmine treatment. Five subjects with AD (3 males, age 70 ± 11 years) were recruited. Cognition was measured with the MMSE and the ADAS-cog performed before beginning rivastigmine treatment via the Exelon Patch (4.6 mg/24 hours for the first month, 9.5 mg/24 hours thereafter), and again after four months of treatment. All MR imaging and spectroscopic data were acquired on a 3T Siemens whole-body MRI. T 2 -weighted images (0.7x0.7x4 mm 3 resolution, TR = 6s, TE = 84 ms) were acquired for MRS voxel placement. MRS data were acquired from an 8 cm 3 volume of interest (TR = 2s, TE = 135 ms) in the posterior cingulate at baseline and after four months of treatment. N -acetylaspartate (NAA), choline (Cho), myo-inositol (Myo), glutamate (Glu), and glutamine (Gln) were measured and normalized to creatine (Cr) for evaluation of changes over time. The ratio of Glu/Cr decreased by 27% (P = 0.062) following treatment, trending towards statistical significance. No other changes in metabolite ratios were observed. The average MMSE and ADAS-cog scores at baseline were 24.8 ± 2.9 and 11.2 ± 5.5, respectively, and were unchanged after 4 months of rivastigmine treatment. Changes in cognitive scores did not correlate with changes in Glu/Cr. Previous studies have found an increase in Glu/Cr in the hippocampus following galantamine treatment and no change in Glu in the hippocampus following donepezil treatment. Along with increasing choline levels there is evidence that rivastigmine modulates the glutamatergic system by increasing the expression of the Glu reuptake carrier resulting in reduced extracellular Glu. This preliminary observation of a trend toward a decrease in Glu/Cr in the posterior cingulate following rivastigmine treatment may be related to the effect of rivastigmine on glutamate uptake. Changes in average metabolite ratios (A) and cognitive scores (B) from baseline to four months (Error bars represent ± 1 standard deviation, # represents p<0.1)" @default.
- W2095668671 created "2016-06-24" @default.
- W2095668671 creator A5011579867 @default.
- W2095668671 creator A5028347310 @default.
- W2095668671 creator A5038290862 @default.
- W2095668671 creator A5041492639 @default.
- W2095668671 creator A5067317602 @default.
- W2095668671 creator A5085059317 @default.
- W2095668671 date "2012-07-01" @default.
- W2095668671 modified "2023-09-27" @default.
- W2095668671 title "IC-P-067: 3T magnetic resonance spectroscopy of the posterior cingulate following rivastigmine treatment in Alzheimer's disease" @default.
- W2095668671 doi "https://doi.org/10.1016/j.jalz.2012.05.100" @default.
- W2095668671 hasPublicationYear "2012" @default.
- W2095668671 type Work @default.
- W2095668671 sameAs 2095668671 @default.
- W2095668671 citedByCount "0" @default.
- W2095668671 crossrefType "journal-article" @default.
- W2095668671 hasAuthorship W2095668671A5011579867 @default.
- W2095668671 hasAuthorship W2095668671A5028347310 @default.
- W2095668671 hasAuthorship W2095668671A5038290862 @default.
- W2095668671 hasAuthorship W2095668671A5041492639 @default.
- W2095668671 hasAuthorship W2095668671A5067317602 @default.
- W2095668671 hasAuthorship W2095668671A5085059317 @default.
- W2095668671 hasConcept C118552586 @default.
- W2095668671 hasConcept C126322002 @default.
- W2095668671 hasConcept C126838900 @default.
- W2095668671 hasConcept C134018914 @default.
- W2095668671 hasConcept C143409427 @default.
- W2095668671 hasConcept C169900460 @default.
- W2095668671 hasConcept C2776332859 @default.
- W2095668671 hasConcept C2778733324 @default.
- W2095668671 hasConcept C2779134260 @default.
- W2095668671 hasConcept C2779483572 @default.
- W2095668671 hasConcept C2779896295 @default.
- W2095668671 hasConcept C2780904820 @default.
- W2095668671 hasConcept C2781123555 @default.
- W2095668671 hasConcept C2989005 @default.
- W2095668671 hasConcept C71924100 @default.
- W2095668671 hasConcept C90924648 @default.
- W2095668671 hasConceptScore W2095668671C118552586 @default.
- W2095668671 hasConceptScore W2095668671C126322002 @default.
- W2095668671 hasConceptScore W2095668671C126838900 @default.
- W2095668671 hasConceptScore W2095668671C134018914 @default.
- W2095668671 hasConceptScore W2095668671C143409427 @default.
- W2095668671 hasConceptScore W2095668671C169900460 @default.
- W2095668671 hasConceptScore W2095668671C2776332859 @default.
- W2095668671 hasConceptScore W2095668671C2778733324 @default.
- W2095668671 hasConceptScore W2095668671C2779134260 @default.
- W2095668671 hasConceptScore W2095668671C2779483572 @default.
- W2095668671 hasConceptScore W2095668671C2779896295 @default.
- W2095668671 hasConceptScore W2095668671C2780904820 @default.
- W2095668671 hasConceptScore W2095668671C2781123555 @default.
- W2095668671 hasConceptScore W2095668671C2989005 @default.
- W2095668671 hasConceptScore W2095668671C71924100 @default.
- W2095668671 hasConceptScore W2095668671C90924648 @default.
- W2095668671 hasIssue "4S_Part_1" @default.
- W2095668671 hasLocation W20956686711 @default.
- W2095668671 hasOpenAccess W2095668671 @default.
- W2095668671 hasPrimaryLocation W20956686711 @default.
- W2095668671 hasRelatedWork W1963557149 @default.
- W2095668671 hasRelatedWork W1975249752 @default.
- W2095668671 hasRelatedWork W1986939346 @default.
- W2095668671 hasRelatedWork W2014004659 @default.
- W2095668671 hasRelatedWork W2021836195 @default.
- W2095668671 hasRelatedWork W2056053677 @default.
- W2095668671 hasRelatedWork W2087374214 @default.
- W2095668671 hasRelatedWork W2147929974 @default.
- W2095668671 hasRelatedWork W2443557387 @default.
- W2095668671 hasRelatedWork W3164277805 @default.
- W2095668671 hasVolume "8" @default.
- W2095668671 isParatext "false" @default.
- W2095668671 isRetracted "false" @default.
- W2095668671 magId "2095668671" @default.
- W2095668671 workType "article" @default.